Search results for: 'biologics contract development'

29 Jun 2020  |  Global  |  Technology Research

Decoding Technological Advances in Biomanufacturing

Growing Viral Vector Contract Development Manufacturing Landscape

Infographics

×

The rise in gene therapies over the last few years has created a huge opportunity for viral vector Contract Research Development Organization (CMO/CDMO) to fill the gap of high demand and shortage of viral vectors. As of January 2020, the US Food and Drug Administration FDA has approved four gene therapies and claims to have over 900 therapies i...

08 Jun 2022  |  North America  |  Market Research

Growth Opportunities in Sterile Injectable Outsourcing

Biologics Drive the Future Growth Potential of Sterile Injectable Outsourcing

Infographics

×

Injectables constitute one of the fastest growing segments in the pharmaceuticals space. Many drugs, including biologics, are going off patent in next 3 or 4 years, which will lead to an increase in the demand for generics and biosimilar injectables. The increase in onshoring and nearshoring of biopharmaceutical products for COVID-19 and next-gen...

This Frost & Sullivan study provides an overview of the research and development (R&D) budget of the US Department of Defense (DoD) for the period between FY2023 and FY2029. The study outlines the DoD’s budget activities and funding distribution amongst military branches and provides a forecast with spending estimates. It highlights the trends infl...

The scope of this research service is to provide an in-depth analysis of the contract research opportunities available in the European therapeutic market. It analyses the revenue potential, market dynamics, trends and competitive structure. The European Contract Research Outsourcing (CRO) revenues have been derived from the preclinical and clinical...

24 Jul 2020  |  North America  |  Market Research

Curative Oncology and Rare Disease Therapies Transforming the Global Biologics Market, 2020–2024

Strategic Collaborations with Specialty Bio-CDMOs will Continue to Drive Growth Opportunities in Antibody-drug Conjugates and Gene Therapies

Infographics

×

Key Issues Addressed

With this research service, Frost & Sullivans Transformational Health team provides critical insights into the global biologics industry highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The global biologics market covered in this study includes 4 major segments – antibody therapies, r...

Developed Asia-Pacific economies, such as Japan, South Korea, Taiwan, Australia, and Singapore, are at the forefront of advanced technology and industrial innovation. These countries have strong ambitions to sustain global tech leadership. However, they face strategic pressures from shifting geopolitics, energy-security challenges, and efforts to r...

Many technologies operate in parallel as a matter of redundancy. Others operate in parallel to facilitate change management and business transformation from an old version to a new version. It is now often said that the transformation from old stack to new stack for software development will be achieved through cloud native microservices architectu...

Scope of the report The research report includes the following segments: Product scope: Contract food services under facilities management market Geographic scope: Southeast Asia - Singapore, Malaysia, Thailand, Indonesia, Vietnam End-user scope: Industrial, Office, Hospital, Education, Government Revenue forecasts, outsource rates, market segmen...

This whitepaper analyses the significance of manufacturing through industrial clusters. It draws insights from some of the success stories both in India and from other nations. It shows that India, by various initiatives such as the ‘Make in India’ programme and National Manufacturing Policy help boost the manufacturing growth in India. Manufacturi...